Synthesis of HIV NNRTI Doravirine Analogues via Visible-Light Photoredox Decarboxylative Cross-Coupling

Published as part of the Special Topic Modern Coupling Approaches and their Strategic Applications in Synthesis

Abstract

A C(sp²)–C(sp³) decarboxylative cross-coupling reaction utilizing dual nickel and photoredox catalysis for rapid parallel synthesis of diverse C-ring analogues of the HIV NNRTI clinical candidate doravirine is developed and described herein. This protocol features an alkylation with readily available and inexpensive methyl bromoacetate followed by hydrolysis to prepare an advanced doravirine intermediate, which undergoes decarboxylative cross-coupling with a variety of aryl and heteroaryl bromides. The mildness, broad applicability, and sustainability of the current methodology are improvements over previously reported procedures and allow for rapid parallel synthesis of analogues. The optimization and scope of this method are reported.

Key words

HIV - photoredox catalysis - visible light - decarboxylative coupling - NNRTI

• References

• 1 World Health Organization Data and Statistics. http://www.who.int/hiv/en (accessed May 16, 2018).
• 2 Lohse N. Hansen A.-BE. Pedersen G. Kronborg G. Gersoft J. Sørensen HT. Væth M. Obel N. Ann. Int. Med. 2007; 146: 87
• 3 Palella FJ. Jr. Delaney KM. Moorman AC. Loveless MO. Fuhrer J. Satten GA. Aschman DJ. Holmberg SD. N. Engl. J. Med. 1998; 338: 853
• 4 Deeks SG. The Lancet 2013; 382: 1525
• 5 Côte B. Burch JD. Asante-Appiah E. Bayly C. Bedard L. Blouin M. Campeau L.-C. Cauchon E. Chan M. Chefson A. Coulombe N. Cromlish W. Debnath S. Deschenes D. Dupont-Gaudet K. Falgueyret J.-P. Forget R. Gagne S. Gauvreau D. Girardin M. Guiral S. Langlois E. Li CS. Nguyen N. Papp R. Plamondon S. Roy A. Roy S. Seliniotakis R. St-Onge M. Ouellet S. Tawa P. Truchon J.-F. Vacca J. Wrona M. Yan Y. Ducharme Y. Bioorg. Med. Chem. Lett. 2014; 24: 917
• 6a Gatell JM. Morales-Ramirez JO. Hagins DP. Thompson M. Keikawus A. Hoffmann C. Rugina S. Osiyemi O. Escoriu S. Dretler R. Harvey C. Xu X. Teppler H. J. Int. AIDS Soc. 2014; 17: 19532
• 6b Gulick R. J. Int. AIDS Soc. 2014; 17: 19528
• 7a Campeau L.-C. Chen Q. Gauvreau D. Girardin M. Belyk KM. Maligres PE. Zhou G. Gu C. Zhang W. Tan L. O’Shea PD. Org. Process Res. Dev. 2016; 20: 1476
• 7b Gauthier DR. Sherry BD. Cao Y. Journet M. Humphrey G. Itoh T. Mangion I. Tschaen DM. Org. Lett. 2015; 17: 1353
• 8 ElMarrouni A. Campbell M. Perkins JJ. Converso A. Org. Lett. 2017; 19: 3071
• 9 Tributyl(iodomethane)stannyl: CAS 66222-29-5; $90/g from Synthonix.

For selected reviews, see:
• 10a Schultz DM. Yoon TP. Science 2014; 343: 941
• 10b Prier CK. Rankic DA. MacMillan DW. C. Chem. Rev. 2013; 113: 5322
• 10c Yoon TP. ACS Catal. 2013; 3: 895
• 10d Xi Y. Yi H. Lei A. Org. Biomol. Chem. 2013; 11: 2387
• 10e Reckenthler M. Griesbeck AG. Adv. Synth. Catal. 2013; 355: 2727
• 10f Garlets ZJ. Nguyen JD. Stephenson CR. J. Isr. J. Chem. 2014; 54: 351
• 10g Douglas JJ. Nguyen JD. Cole KP. Stephenson CR. J. Aldrichimica Acta 2014; 47: 15
• 10h Nicewicz DA. Nguyen TM. ACS Catal. 2014; 4: 355
• 11a Zuo Z. MacMillan DW. C. J. Am. Chem. Soc. 2014; 136: 5257
• 11b Chu L. Ohta C. Zuo Z. MacMillan DW. C. J. Am. Chem. Soc. 2014; 136: 10886
• 11c Noble A. MacMillan DW. C. J. Am. Chem. Soc. 2014; 136: 11602
• 12 Gutierrez-Bonet A. Tellis JC. Matsui JK. Vara BA. Molander GA. ACS Catal. 2016; 6: 8004
• 13 Devery JJ. III. Douglas JJ. Nguyen JD. Cole KP. Flowers RA. II. Stephenson CR. J. Chem. Sci. 2015; 6: 537
• 14 Luo J. Zhang J. ACS Catal. 2016; 6: 873
• 15 Savoie PR. Welch JT. Chem. Rev. 2015; 115: 1130
• 16a Meanwell NA. J. Med. Chem. 2018;
• 16b Gillis EP. Eastman KJ. Hill MD. Donnelly DJ. Meanwell NA. J. Med. Chem. 2015; 58: 8315